ARCHIVES

Funding Opportunities: NCI Offers Funds To Develop, Validate Mouse Models

This article is from The Cancer Letter archive.

Vol. 24 No. 44 | November 20, 1998

Download PDF Visit The Full Archive

Related Articles

Phase III Trial: Panobinostat Increases PFS by Four Months

September 26, 2014

In Brief: Weicker Heads New Group For More Spending On Medical Research; Committee Oks Sullivan

March 3, 1989

FDA Advisors Discuses Establishment of Standards for Showing Equivalence

December 17, 1999

CAB Reluctantly Approves Use Of Contract To Support Cancer Journals

February 15, 1985

New Regimens May Benefit Multiple Myeloma Patients

January 28, 2005

Starr Foundation Gives $100 Million To Form Cancer Consortium.

September 29, 2006